By Nick O'Brien
It’s always exciting for us when a Medrio customer wins regulatory approval for a new product. We’d like to congratulate KindredBio, an organization doing fascinating research in the Animal Health sector, on their recent approval of Mirataz. KindredBio used Medrio EDC in clinical trials for Mirataz, and we’re proud to have partnered with them in … Read More →
By Nick O'Brien
The often daunting challenges of pharmaceutical development are no secret: throughout the industry, stakeholders experience hefty price tags, lengthy timelines, and difficulties with patient recruitment and retention. According to Pharmaceutical Research and Manufacturers, it takes an average of ten years and $2.6 billion to develop a new drug – and there is typically just a … Read More →
By Nick O'Brien
After months of development, extensive beta testing, and lots of user feedback, we’ve reached a milestone moment here at Medrio: Medrio eConsent, our tablet application enhancing electronic informed consent in clinical trials, is now live! Last week, the platform officially became available on Google Play. Getting to this moment was a collaborative effort, with Medrio … Read More →
By Nick O'Brien
Clinical research is undergoing a period of rapid transformation. New technology that focuses on greater speed and efficiency is shaking up all aspects of the research process, from Phase 1 clinical trials to post-market surveillance. The growing use of artificial intelligence, eClinical tools, and mHealth is helping researchers to more quickly overcome challenges with patient … Read More →
By Nick O'Brien
Today’s blog post comes to us from Nathan Waller, Medrio’s managing Director of EMEA and a former Director of Business Development at a global CRO. For CROs, clinical research can at times feel like walking a tightrope. If you can keep your balance, success is waiting for you on the other side of the chasm, … Read More →
By Nick O'Brien
Last month, we launched a social media campaign to raise money for cancer research. We put out a call on our social channels, as well as here on the Medrio blog, for photos of our favorite cat, Dr. GoodData, pledging to donate a dollar to the UCSF Helen Diller Family Comprehensive Cancer Center for each … Read More →
By Nick O'Brien
In the time since our 2017 equity investment, one of Medrio’s central goals has been building out the resources to expand our existing international footprint. We established servers in Europe. We hired new staff in the Asia Pacific (APAC) region and elsewhere. And next month, from November 11 to 13, we’re heading to Tokyo for … Read More →
By Nick O'Brien
Contract research organizations have a fine line to walk. On one hand, they face the same mandate as anyone else involved with clinical research and drug development: delivering new treatments to market as rapidly as possible. This urgency has caused CROs to invest heavily in eClinical technology and other resources that unlock game-changing efficiencies, accelerating … Read More →
By Nick O'Brien
Clinical research looks much different today than it did just a few years ago. Whether it’s new approaches to clinical trial design, a surge in eClinical technology, or recent medical breakthroughs, the industry is under the influence of a wide array of forces driving its evolution. For CROs, some of the greatest impact has come … Read More →
By Nick O'Brien
This October, Fred Martin, Vice President of Product and Engineering at Medrio, will be at MAGI 2018 West to give a presentation and interface with industry professionals. Here’s Fred on his upcoming trip to San Diego for the conference. As we enter my favorite season (football, sweaters, autumn colors and the holidays), Medrio is approaching … Read More →